LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)
$0.054 0.01 (22.7273%)
Analysed LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) News Sources
Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book
04-09-2026
yahoo.com
Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million
22-09-2026
yahoo.com
Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners
22-09-2026
yahoo.com
Sydnexis Announces Royalty Agreement with Ligand for Ryjunea®
22-09-2026
yahoo.com
Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million
24-09-2026
yahoo.com
Twilio downgraded, Synopsys upgraded: Wall Street's top analyst calls
25-09-2026
yahoo.com
Ligand (LGND)-AvenCell Deal: Most of the Funding Is Tied to Milestones
27-09-2026
yahoo.com
Is Ligand Pharmaceuticals (LGND) Using AvenCell CAR-T Royalties To Redefine Its Cash-Flow Playbook?
29-09-2026
yahoo.com
Ligand Pharmaceuticals (LGND) Stock May Be 27% Undervalued After A New Royalty Deal
29-09-2026
yahoo.com
Is Ligand Pharmaceuticals (LGND) Below Fair Value As It Funds AvenCell?
29-09-2026
yahoo.com
What is the current price of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The current price of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is $0.054.
LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) since the previous trading day is $0.01.
LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) since the previous trading day is 22.7273%.
What is the most recent average sentiment score for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The most recent average sentiment score for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The most recent sentiment for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is .
SEC-8K** Filing Available For LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.